Tasocitinib预计将推向市场，杰弗里·斯托尔说。他是一家总部设在康涅狄格州诺沃克的医药市场研究公司IMSHealth的分析师。
Tasocitinib is expected to make it to market, says Jeffrey Stoll, an analyst at IMS Health, a pharmaceutical market research company headquartered in Norwalk, Connecticut.
Tasocitinib预计将推向市场，杰弗里·斯托尔说。他是一家总部设在康涅狄格州诺沃克的医药市场研究公司IMSHealth的分析师。
Tasocitinib is expected to make it to market, says Jeffrey Stoll, an analyst at IMS Health, a pharmaceutical market research company headquartered in Norwalk, Connecticut.
应用推荐